LYVE-1-targeted microbeads (BioTime/Stanford University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLYVE-1-targeted microbeads (BioTime/Stanford University)
Drug Alias NameLYVE-1-targeted microbeads (Asterias Biotherapeutics/Stanford University)
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationLymphatic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsterias Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsterias Biotherapeutics IncStanford UniversityLineage Cell Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationLymphatic DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A